What is Moderna's accrued sales returns?

Moderna (MRNA) reported accrued sales returns of $470.00M in Q1 2026.

How has Moderna's accrued sales returns changed year-over-year?

Moderna's accrued sales returns increased by 39.5% year-over-year, from $337.00M to $470.00M.

Accrued sales returns

Moderna Accrued sales returns decreased by 7.7% to $470.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 39.5%, from $337.00M to $470.00M.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ4 2022

Last reportedQ1 2026May 1, 2026

Metric ID: other_contract_with_customer_refund_liability

Historical Data

12 periods

	Q4 '22	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$0.00	$184.00M	$556.00M	$574.00M	$554.00M	$403.00M	$370.00M	$337.00M	$308.00M	$426.00M	$509.00M	$470.00M
QoQ Change	—	—	+202.2%	+3.2%	-3.5%	-27.3%	-8.2%	-8.9%	-8.6%	+38.3%	+19.5%	-7.7%
YoY Change	—	—	—	—	—	+119.0%	-33.5%	-41.3%	-44.4%	+5.7%	+37.6%	+39.5%

Range$0.00 – $574.00M

Avg YoY Growth+11.8%

Median YoY Growth+5.7%

Product Breakdown

View all

Segment	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '25
Net product sales	$184.00M	$556.00M	$574.00M	$554.00M	$403.00M	$509.00M
Total	$184.00M	$556.00M	$574.00M	$554.00M	$403.00M	$509.00M

Frequently Asked Questions

What is Moderna's accrued sales returns?: Moderna (MRNA) reported accrued sales returns of $470.00M in Q1 2026.
How has Moderna's accrued sales returns changed year-over-year?: Moderna's accrued sales returns increased by 39.5% year-over-year, from $337.00M to $470.00M.